by Raynovich Rod | Jun 27, 2017 | Biopharmaceuticals, Clinical Diagnostics and Tools
Genomics and the Future of Personalized Medicine and Diagnostics Description of Track The opening plenary of the Personalized Medicine & Diagnostics Track will feature J. Craig Venter, Founder, Chairman and Chief Executive Officer of the J. Craig Venter Institute,...
by Rod Raynovich | Sep 21, 2010 | 2023-24 Life Science Portfolios, BIOgraph
Sequenom (SQNM) $7, Market Cap $529M, 76M Sh. Outstanding Sequenom presented a financial update and their plans for their T21 trisomy 21 noninvasive pre-natal test for fetal gene and chromosomal abnormalities. The Company plans to launch a CLIA LDT (lab developed...